(−)‐Epicatechin rescues the As2O3‐induced HERG K+ channel deficiency possibly through upregulating transcription factor SP1 expression

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of biochemical and molecular toxicology

• Publication date

  2017-11-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1002/jbt.21966PMID 28768059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (–)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway

  2017cited by this paper
• Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia

  2016cited by this paper
• Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency

  2015cited by this paper
• Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity.

  2014cited by this paper
• Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.

  2014cited by this paper
• Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.

  2013cited by this paper
• Large T-antigen up-regulates Kv4.3 K⁺ channels through Sp1, and Kv4.3 K⁺ channels contribute to cell apoptosis and necrosis through activation of calcium/calmodulin-dependent protein kinase II.

  2012cited by this paper
• Anthocyanins in cardiovascular disease.

  2011cited by this paper
• Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice

  2010cited by this paper
• Drug-Induced Long QT Syndrome

  2010cited by this paper
• Transcriptional Control of KCNQ Channel Genes and the Regulation of Neuronal Excitability

  2010cited by this paper
• Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion.

  2010cited by this paper
• HERG1 channelopathies

  2009cited by this paper
• Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.

  2008cited by this paper
• hERG channel trafficking: novel targets in drug-induced long QT syndrome.

  2007cited by this paper
• (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans.

  2006cited by this paper
• hERG potassium channels and cardiac arrhythmia

  2006cited by this paper
• Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart.

  2005cited by this paper
• Mechanisms of arsenic-induced prolongation of cardiac repolarization.

  2004cited by this paper
• Effect of arsenic trioxide on QT interval in patients with advanced malignancies.

  2003cited by this paper
• Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

  2002cited by this paper
• The arsenic eaters of Styria: a different picture of people who were chronically exposed to arsenic

  2001cited by this paper
• United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

  2001cited by this paper
• Histone Deacetylase 1 Can Repress Transcription by Binding to Sp1

  1999cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

  1997cited by this paper

• SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy.

  2022cites this paper
• The systemic inflammatory response syndrome in acute antipsychotic poisoning

  2020cites this paper